Skip to main content
384 search results for:

Cyclophotocoagulation 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 01-12-2024 | Glaucoma | OriginalPaper

    Micropulse transscleral cyclophotocoagulation (MP-CPC): efficacy endpoints for the treatment of refractory paediatric glaucoma - a retrospective case-series

    Glaucoma is a major cause of irreversible visual deterioration [ 1 , 2 ]. In children, glaucoma is categorized as primary or secondary. Primary paediatric glaucoma includes primary congenital glaucoma (PCG) and juvenile open-angle glaucoma (JOAG).

  2. Open Access 01-12-2022 | Glaucoma | OriginalPaper

    Intermediary inflammatory reaction after micropulse cyclophotocoagulation diode therapy: a case report

    Laser cyclophotocoagulation (CPC) procedures have become a common surgical method used in refractory glaucoma patients to lower intraocular pressure (IOP). The principle is to reduce aqueous humor formation by laser-assisted destruction of the …

  3. 01-02-2022 | Glaucoma | OriginalPaper

    Transscleral cyclophotocoagulation with MicroPulse® laser versus cyclophotocoagulation with continuous diode laser in patients with open-angle glaucoma

    Glaucoma is one of the main causes of irreversible blindness worldwide [ 1 ]. Glaucoma therapies, conservative or surgical, are designed either to increase the outflow or to reduce the production of the aqueous humor in order to decrease the …

  4. 09-12-2022 | Glaucoma | OriginalPaper

    Six year outcomes of combined phacoemulsification surgery and endoscopic cyclophotocoagulation in refractory glaucoma

    Glaucoma is the leading global cause of irreversible blindness [ 1 – 4 ]. The focus of treatment remains reduction in intraocular pressure (IOP) [ 5 , 6 ], either through aqueous suppression or increasing outflow [ 7 ]. Trabeculectomy remains the …

  5. 01-04-2022 | Glaucoma

    Micropulse transscleral cyclophotocoagulation in a Taiwanese population: 2-year clinical outcomes and prognostic factors

    A growing body of studies have examined the therapeutic efficacy and safety profiles of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in the management of refractory glaucoma. These studies introduced repetitive micropulses of diode …

  6. 01-05-2022 | Glaucoma

    Outcomes of a combination of augmented MicroPulse and limited Continuous Wave Cyclophotocoagulation in patients with refractory glaucoma

    Transscleral cyclophotocoagulation (TSCPC) is used to lower intraocular pressure (IOP) in patients with advanced glaucoma, often as an alternative therapy to more invasive surgical procedures such as trabeculectomies and glaucoma drainage devices.

  7. Open Access 01-12-2023 | Glaucoma | OriginalPaper

    Transscleral vs endoscopic cyclophotocoagulation: safety and efficacy when combined with phacoemulsification

    Laser cyclophotocoagulation has been proposed as a potentially safe and effective intraocular pressure (IOP)-lowering tool. During cyclophotocoagulation, the laser can be delivered through either a transscleral or an endoscopic approach to the …

  8. 18-04-2023 | Glaucoma | OriginalPaper

    One-year outcomes of combined phacoemulsification and viscogoniosynechialysis with and without endoscopic cyclophotocoagulation in primary angle-closure glaucoma

    Glaucoma is the leading cause of irreversible blindness worldwide. Primary angle-closure glaucoma (PACG) is a subtype of primary glaucoma with the highest prevalence in the Asian population. It is estimated that 32.04 million people aged 40–80 …

  9. Open Access 01-12-2021 | Glaucoma | OriginalPaper

    Correlation between intraocular pressure reduction and anterior chamber aqueous flare after micropulse transscleral cyclophotocoagulation

    Glaucoma is the leading cause of blindness worldwide. The damage to the optic nerve and visual field caused by glaucoma is progressive and irreversible [ 1 ]. The only reliable evidence-based treatment for glaucoma is the lowering of intraocular …

  10. Open Access 03-02-2022 | Glaucoma | OriginalPaper

    First and second transscleral cyclophotocoagulation treatments provide similar intraocular pressure-lowering efficacy in patients with refractory glaucoma

    Glaucoma is a chronic, progressive optic neuropathy with a multi-factorial etiology [ 1 – 5 ]. It is the leading cause of irreversible blindness worldwide [ 6 – 8 ]. An irreversible damage of the optic nerve and a progressive loss of nerve fibers …

  11. 01-08-2021 | Glaucoma

    Two-year efficacy after first transscleral controlled cyclophotocoagulation in patients with and without pseudoexfoliation

    Glaucoma is one of the leading causes of irreversible blindness in the world. Much effort has been made to develop surgical techniques for lowering intraocular pressure (IOP) to treat glaucoma [ 1 – 5 ]. Aqueous outflow obstruction is the main …

  12. 01-11-2021 | Glaucoma

    Comparative efficacy and safety of micropulse transscleral laser cyclophotocoagulation using different duration protocols in eyes with good visual acuity

    Glaucoma treatment aims to reduce the intraocular pressure (IOP), by decreasing the production of aqueous humour, or increasing the aqueous outflow or both [ 1 ]. IOP reduction can be achieved by several treatment strategies, including topical and …

  13. 01-10-2021 | Glaucoma

    Real-life experience of micropulse transscleral cyclophotocoagulation (MP-TSCPC) in advanced and uncontrolled cases of several glaucoma types: a multicentric retrospective study

    Micropulse transscleral cyclophotocoagulation (MP-TSCPC) is a relatively new weapon in our therapeutic arsenal for treating refractory advanced glaucoma cases. Previously available treatment possibilities were continuous wave transscleral …

  14. 01-04-2021 | Glaucoma | OriginalPaper

    Transscleral cyclophotocoagulation with MicroPulse® laser versus Ahmed valve implantation in patients with advanced primary open-angle glaucoma

    Advanced open-angle glaucoma is characterized by uncontrolled intraocular pressure (IOP) and substantial visual field deterioration (MD < − 12.00 dB) with evidence of optic neuropathy despite maximal therapy [ 1 ]. These cases are challenging, even …

  15. Open Access 01-12-2020 | Glaucoma | OriginalPaper

    Case report – Acute Corneal Subepithelial Hydrops (ACSH) during Micropulse Transscleral Cyclophotocoagulation (MPTSC)

    Micropulse transscleral cyclophotocoagulation (MPTSC; IRIDEX Laser Systems, Mountain View, CA) was approved by the Food and Drug Administration in 2015 as a treatment for glaucoma. The laser system delivers a series of short pulses of laser energy …

  16. 01-09-2020 | Glaucoma | OriginalPaper

    Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma—18 months follow-up

    The aim of this study is to evaluate the clinical outcomes of micropulse transscleral cyclophotocoagulation (mTSCPC) in cases of refractory glaucoma. Patients with refractory glaucoma were selected to undergo mTSCPC, using the MP3 handpiece from …

  17. 01-05-2020 | Glaucoma | OriginalPaper

    Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma

    Glaucoma remains the leading causes of irreversible blindness worldwide, with intraocular pressure being the only modifiable risk factor [ 1 ]. Several therapeutic strategies are deemed effective to reduce glaucoma progression including topical …

  18. Open Access 01-12-2022 | Glaucoma | OriginalPaper

    Association between endoscopic cyclophotocoagulation and vitreous prolapse in trabeculectomy: a case report

    Vitreous prolapse is an uncommon complication seen in less than 0.5% of glaucoma filtration surgery [ 1 ]. Possible risk factors include aphakia, a subluxed or dislocated lens or eyes with underlying zonular weakness. Zonular weakness can be …

  19. 24-01-2023 | Glaucoma | OriginalPaper

    Comparison of Outcomes of Phacoemulsification Combined with Endoscopic Cyclophotocoagulation, iStent, or Both in the Management of Open-Angle Glaucoma

    Glaucoma is a group of progressive optic neuropathies, and is the leading cause of irreversible blindness, worldwide [ 1 , 2 ]. In 2013, the number of adults between 40 and 80 years of age with glaucoma was estimated to be 64.3 million. It is …

  20. Open Access 23-10-2022 | Glaucoma | OriginalPaper

    A multicenter prospective comparative study evaluating cataract surgery and endoscopic cyclophotocoagulation either with or without iStent inject implantation in Brazilian patients with glaucoma

    Glaucoma is the leading cause of irreversible blindness worldwide [ 1 ]. A meta-analysis of 50 population-based studies encompassing over a quarter of a million individuals estimated the global prevalence of glaucoma for those aged 40 to 80 years …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.